By Adam Jones, Market Realist
Among the well-known cannabis stocks (SEED-TSE) such as Canopy Growth (WEED) and Aurora Cannabis (ACB) (ACBFF), Aphria (APHQF) has been one of the worst performers with a YTD loss of 52%. The company reported its earnings on August 1, and the stock has declined 7.3% since.
Aphria Analysts’ NTM Recommendation and Target 2018-08-04
The consensus ratings on Aphria also remained unchanged from the last month. The overall recommendation for the company was a “buy” over the next-12-month period, which is similar to what we saw for the two companies we discussed earlier. Out of the eight analysts, three maintained a “strong buy” recommendation on the stock, and four analysts maintained a “buy” on Aphria.
As we see in the above chart, only one analyst maintained a “hold” recommendation on Aphria, while none had a “sell” or a “strong sell” on the stock.
Aphria’s current market price of 9.8 Canadian dollars remains significantly depressed from the consensus mean price target of 22.9 Canadian dollars as of the date of this writing. However, the prices fell slightly from 23.3 Canadian dollars a month ago. Based on the closing price of Aphria on August 8, the consensus mean target showed about 133% upside.